Treatment with Isorhamnetin Protects the Brain Against Ischemic Injury in Mice

Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy

(2016) Alba Simats et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Inhibition of Acute Lung Injury by TNFR-Fc through Regulation of an Inflammation-Oxidative Stress Pathway

(2016) Yuan Weifeng et al.   PLoS One

Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies

(2015) Glen C Jickling et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen-glucose deprivation

(2015) Wenlu Li et al.   JOURNAL OF NEUROCHEMISTRY

Quercetin and isorhamnetin aglycones are the main metabolites of dietary quercetin in cerebrospinal fluid

(2015) Wiesław Wiczkowski et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice

(2015) Emil Zeynalov et al.   PLoS One

Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease

(2015) Hiroto Takahashi et al.   Scientific Reports

Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats

(2013) Feng Wu et al.   ATHEROSCLEROSIS

Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities

(2013) Ramon Rodrigo et al.   CNS & Neurological Disorders-Drug Targets

Epidemiology of stroke and its subtypes in Chinese vs white populations: A systematic review

(2013) C.-F. Tsai et al.   NEUROLOGY

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro

(2013) Jing Sun et al.   PLoS One

Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes

(2013) Ji Hye Yang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction

(2012) Nicholas L Weilinger et al.   ACTA PHARMACOLOGICA SINICA

Reperfusion Rather than Ischemia Drives the Formation of Ubiquitin Aggregates After Middle Cerebral Artery Occlusion

(2012) Karin Hochrainer et al.   STROKE

Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation

(2011) Bing Sun et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Pathophysiology, treatment, and animal and cellular models of human ischemic stroke

(2011) Trent M Woodruff et al.   Molecular Neurodegeneration

The immunology of stroke: from mechanisms to translation

(2011) Costantino Iadecola et al.   NATURE MEDICINE

Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease

(2011) Yi Yang et al.   STROKE

Epidemiology and the Global Burden of Stroke

(2011) Debraj Mukherjee et al.   World Neurosurgery

Omega-3 Polyunsaturated Fatty Acid Supplementation Confers Long-Term Neuroprotection Against Neonatal Hypoxic–Ischemic Brain Injury Through Anti-Inflammatory Actions

(2010) Wenting Zhang et al.   STROKE

An Epidemiological Survey of Stroke in Lhasa, Tibet, China

(2010) Yuhua Zhao et al.   STROKE

Pathology and new players in the pathogenesis of brain edema

(2009) Sukriti Nag et al.   ACTA NEUROPATHOLOGICA

Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury

(2009) Najuan Zhang et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Edema formation in the hyperacute phase of ischemic stroke

(2009) Tibo Gerriets et al.   JOURNAL OF NEUROSURGERY

The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema*

(2008) Emil Zeynalov et al.   CRITICAL CARE MEDICINE